<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02701062</url>
  </required_header>
  <id_info>
    <org_study_id>CP2015-2</org_study_id>
    <nct_id>NCT02701062</nct_id>
  </id_info>
  <brief_title>AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)</brief_title>
  <acronym>ATLAS</acronym>
  <official_title>AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AtriCure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AtriCure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients without a documented history of AF but who present with a CHA2DS2- VASc of =&gt; 2 and
      HASBLED of =&gt; 2 and will undergo a valve or CABG (structural heart) procedure with direct
      visual access to the LAA will be eligible to participate based upon the inclusion and
      exclusion criteria defined in this protocol. Up to 2000 patients will enroll at up to 40
      sites and will be randomized 2:1 (2 with AtriClip to 1 without AtriClip. Subjects who not
      develop Post-operative Atrial Fibrillation (POAF) will be followed for 30 days for safety.
      Subjects who develop POAF and receive the AtriClip will be followed for 365 days post index
      procedure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of subjects with perioperative complications associated with AtriClip placement</measure>
    <time_frame>Within any 24 hour period during the first 2 days post-index procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of subjects with intraoperative successful exclusion of LAA.</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Successful exclusion of LAA is defined as no (0 mm) flow between LAA and LA and &lt; 5 mm LAA remnant by intraoperative TEE with Doppler.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of subjects with composite event rates between the group of subjects diagnosed with POAF</measure>
    <time_frame>365 days post index procedure</time_frame>
    <description>Events to be evaluated include: Thromboembolic &amp; Hemorrhagic Events such as cerebrovascular accident (CVA), transient ischemic attack (TIA), peripheral ischemia, hemorrhagic stroke, neurologic bleed, gastrointestinal (GI) bleeds, or other major bleeding event.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Post-Operative Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>LAA Exclusion with AtriClip®</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>LAA Exclusion with AtriClip®: AtriClip® is used per label and is not experimental.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medical Management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Medical Management: Standard of Care Oral Anticoagulation Therapy at the discretion of the Investigator.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AtriClip® Gillinov-Cosgrove™ LAA Exclusion Systems</intervention_name>
    <arm_group_label>LAA Exclusion with AtriClip®</arm_group_label>
    <other_name>AtriClip FLEX (ACH2)</other_name>
    <other_name>AtriClip Long (LAA)</other_name>
    <other_name>AtriClip Standard (ACH1)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anticoagulation Therapy</intervention_name>
    <description>Anticoagulation Therapy - Standard of Care at the discretion of the Investigator.</description>
    <arm_group_label>Medical Management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients satisfying the following criteria will be considered the screening population and
        will be eligible for participation:

          -  Age &gt; 18 years male or female.

          -  Scheduled for any non-mechanical valve and/or CABG (structural heart) procedure where
             direct access to the LAA is expected.

          -  No documented preoperative AF.

          -  CHA2DS2-VASc score of =&gt; 2.

          -  HASBLED score of =&gt; 2.

          -  Acceptable surgical candidate, including use of general anesthesia.

          -  Willing and able to provide written informed consent.

        Exclusion Criteria:

        Patients satisfying the following criteria will not be eligible for participation:

          -  Redo cardiac surgery.

          -  Mechanical heart valve or other anticipated or current requirement for anticoagulation
             therapy during the post-operative (30 day) period.

          -  Hypercoagulability conditions that may confound the study.

          -  Ejection Fraction &lt; 30.

          -  Left Atrium &gt; 6 cm.

          -  Severe Diastolic Dysfunction.

          -  Requires anticoagulation therapy.

          -  Patient had a stroke/cerebrovascular accident (CVA) within previous 30 days prior to
             signing informed consent.

        Intra-Operative Exclusion Criteria

          -  Presence of thrombus in the left atrium or LAA.

          -  LAA tissue is deemed friable or has significant adhesions (as evaluated by the
             surgeon) near or on the LAA making AtriClip placement overly risky.

          -  Left atrial appendage is outside the range of manufacturer's recommendations - width &lt;
             29mm or &gt; 50mm.

          -  Direct visualization access is not available for AtriClip placement.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sydney Gaynor, MD</last_name>
    <role>Study Chair</role>
    <affiliation>AtriCure, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Rhoades</last_name>
    <phone>513-755-4561</phone>
    <email>mrhoades@atricure.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sharp Memorial Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Kohlmyer</last_name>
      <phone>858-939-7471</phone>
    </contact>
    <investigator>
      <last_name>Karl Limmer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Vesom</last_name>
      <phone>650-724-6921</phone>
    </contact>
    <investigator>
      <last_name>Anson M Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orlando Health Heart Institute</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meghan Tinetti, RN</last_name>
      <phone>321-841-3682</phone>
    </contact>
    <investigator>
      <last_name>Steven J Hoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory St Joseph Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soyna Mathewson, BSN</last_name>
      <phone>678-843-6092</phone>
    </contact>
    <investigator>
      <last_name>Jeffrey Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Francis Heart Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46237</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Molly Miller</last_name>
      <phone>317-893-1948</phone>
    </contact>
    <investigator>
      <last_name>Marc Gerdisch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent Heart Center, Inc.</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jana Fisher</last_name>
      <phone>317-583-6115</phone>
    </contact>
    <investigator>
      <last_name>David Heimansohn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Disha Jenati, BS</last_name>
      <phone>913-588-8830</phone>
    </contact>
    <investigator>
      <last_name>Trip Zorn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Freshta Akbari</last_name>
      <phone>410-328-4563</phone>
    </contact>
    <investigator>
      <last_name>Murtaza Dawood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>United Heart &amp; Vascular Clinic</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Jablonski</last_name>
      <phone>651-241-2816</phone>
    </contact>
    <investigator>
      <last_name>John Grehan, MD, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates Research</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Long, RN</last_name>
      <phone>662-377-7571</phone>
    </contact>
    <investigator>
      <last_name>David Talton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Illya Pushkar</last_name>
      <phone>212-263-4188</phone>
    </contact>
    <investigator>
      <last_name>Deane Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai -St. Luke's</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stella Palencia</last_name>
      <phone>212-844-1456</phone>
    </contact>
    <investigator>
      <last_name>John Puskas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fusilero, MD</last_name>
      <phone>212-241-8905</phone>
    </contact>
    <investigator>
      <last_name>Ahmed El-Eshmawi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Summa Health System</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremy Kick</last_name>
      <phone>330-253-8196</phone>
    </contact>
    <investigator>
      <last_name>Michael Firstenberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Christ Hospital -Linder Research Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David White, RN</last_name>
      <phone>513-585-1777</phone>
    </contact>
    <investigator>
      <last_name>Mario Castillo-Sang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tri-Health</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Krabbe, RN</last_name>
      <phone>513-862-2877</phone>
    </contact>
    <investigator>
      <last_name>J Michael Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shobana Ganesan, PhD</last_name>
      <phone>503-418-8668</phone>
    </contact>
    <investigator>
      <last_name>Donald D Thomas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PinnacleHealth Hospitals</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn McFarlane, LPN</last_name>
      <phone>717-601-0300</phone>
    </contact>
    <investigator>
      <last_name>Mubashir Mumtaz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wellmont CVA Heart Institute</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terrie Walker, RN</last_name>
      <phone>423-230-5000</phone>
    </contact>
    <investigator>
      <last_name>Stanley Gall, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Surgery Clinic</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amber Kirby, RN</last_name>
      <phone>901-747-1268</phone>
    </contact>
    <investigator>
      <last_name>Edward Garrett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Valley Health System</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Lane, RN</last_name>
      <phone>540-536-4399</phone>
    </contact>
    <investigator>
      <last_name>Basel Ramlawi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center/Cherry Hill Campus</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peggy Warnock, MS</last_name>
      <phone>206-320-3294</phone>
    </contact>
    <investigator>
      <last_name>Glen Barnhart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aspirus Wausau Hospital</name>
      <address>
        <city>Wausau</city>
        <state>Wisconsin</state>
        <zip>54401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Burken, MS</last_name>
      <phone>715-847-2273</phone>
      <phone_ext>52638</phone_ext>
    </contact>
    <investigator>
      <last_name>John Johnkoski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2016</study_first_posted>
  <last_update_submitted>December 11, 2017</last_update_submitted>
  <last_update_submitted_qc>December 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>To be determined</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

